What is Nacuity Pharmaceuticals worth?
$52.0Mlast known valuation
Nacuity Pharmaceuticals last raised $8.4M in its Early Stage VC (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Nacuity Pharmaceuticals
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC | $8.4M | ▮ | ▮ |
| Mar 2021 | Early Stage VC | $11.6M | ▮ | ▮ |
| Jun 2017 | Early Stage VC | $9.2M | ▮ | ▮ |
| Nov 2016 | Seed Round | $2.0M | ▮ | ▮ |
How Nacuity Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Nacuity Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Nacuity Pharmaceuticals worth?
- Nacuity Pharmaceuticals's last known valuation is $52.0M.
- How much has Nacuity Pharmaceuticals raised?
- Nacuity Pharmaceuticals has raised $40.6M in total funding across 4 recorded rounds.
- When did Nacuity Pharmaceuticals last raise?
- Nacuity Pharmaceuticals last raised in Dec 2025 (Early Stage VC), raising $8.4M.